导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.63% | 635/758 |
| 近一周 | -1.59% | 528/798 |
| 近一月 | -2.88% | 121/797 |
| 近一季 | 3.06% | 132/789 |
| 近半年 | -11.15% | 601/777 |
| 近一年 | -23.29% | 675/738 |
| 近两年 | -3.99% | 655/679 |
| 近三年 | -27.98% | 593/620 |
| 成立以来 | 35.70% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-7.03% 909/1070 |
-12.53% 974/1101 |
- - |
- - |
| 2025 | -4.68% 945/1065 |
6.35% 317/1014 |
-6.70% 990/1038 |
3.94% 953/1050 |
-7.58% 821/1065 |
| 2024 | -4.53% 690/1011 |
-2.93% 473/960 |
-4.67% 619/983 |
12.54% 416/991 |
-8.32% 839/1011 |
| 2023 | -23.39% 750/952 |
0.15% 621/880 |
-12.70% 823/895 |
-6.02% 368/915 |
-6.77% 654/952 |
| 2022 | -13.40% 140/867 |
-21.36% 595/773 |
18.11% 47/806 |
-12.52% 430/845 |
6.59% 144/867 |
| 2021 | 13.22% 203/740 |
-7.16% 422/580 |
17.15% 206/659 |
-2.21% 265/704 |
6.45% 162/740 |
| 2020 | 67.67% 150/554 |
0.25% 155/419 |
26.13% 181/466 |
12.28% 197/517 |
18.10% 153/554 |
| 2019 | 55.28% 111/410 |
27.38% 525/1149 |
0.82% 255/1231 |
10.96% 99/390 |
8.97% 193/410 |
| 2018 | -25.32% 152/349 |
- - |
- - |
- - |
-18.58% 975/1080 |
| 2017 | 29.84% 43/285 |
- - |
- - |
- - |
- - |
| 2016 | -22.45% 125/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 华宝品质生活股票 VS. 东吴新产业精选股票A(580008) |